These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 24161366)
1. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk. Zolciak-Siwinska A; Bijok M; Jonska-Gmyrek J; Kawczynska M; Kepka L; Bujko K; Michalski W Gynecol Oncol; 2014 Jan; 132(1):93-7. PubMed ID: 24161366 [TBL] [Abstract][Full Text] [Related]
2. Treatment of late recurrent vaginal malignancy after initial radiotherapy for carcinoma of the cervix: an analysis of 73 cases. Xiang-E W; Shu-mo C; Ya-qin D; Ke W Gynecol Oncol; 1998 May; 69(2):125-9. PubMed ID: 9600819 [TBL] [Abstract][Full Text] [Related]
4. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794 [TBL] [Abstract][Full Text] [Related]
5. Image-guided interstitial brachytherapy for recurrent cervical cancer after radiotherapy: A single institution experience. Ren X; Fu Y; Liu Z; Lin X; Qiu L; Li Y; Li H; Bai Y; Wang T Front Oncol; 2022; 12():943703. PubMed ID: 35928866 [TBL] [Abstract][Full Text] [Related]
6. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer. Lee LJ; Viswanathan AN Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049 [TBL] [Abstract][Full Text] [Related]
7. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer. Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915 [TBL] [Abstract][Full Text] [Related]
8. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept. Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784 [TBL] [Abstract][Full Text] [Related]
9. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy. Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564 [TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience. Simha V; Rai B; Patel FD; Kapoor R; Sharma SC; Singh OA; Singla V; Dhanireddy B; Ghoshal S Brachytherapy; 2018; 17(2):345-351. PubMed ID: 29102740 [TBL] [Abstract][Full Text] [Related]
11. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma. Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834 [TBL] [Abstract][Full Text] [Related]
12. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation. Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903 [TBL] [Abstract][Full Text] [Related]
13. DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery. Haie-Meder C; Chargari C; Rey A; Dumas I; Morice P; Magné N Radiother Oncol; 2009 Nov; 93(2):316-21. PubMed ID: 19586673 [TBL] [Abstract][Full Text] [Related]
14. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer. Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165 [TBL] [Abstract][Full Text] [Related]
15. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results. Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174 [TBL] [Abstract][Full Text] [Related]
16. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. Georg P; Pötter R; Georg D; Lang S; Dimopoulos JC; Sturdza AE; Berger D; Kirisits C; Dörr W Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):653-7. PubMed ID: 21345618 [TBL] [Abstract][Full Text] [Related]
17. Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer. Vargo JA; Kim H; Houser CJ; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S Brachytherapy; 2015; 14(1):9-15. PubMed ID: 25456026 [TBL] [Abstract][Full Text] [Related]
18. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer. Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698 [TBL] [Abstract][Full Text] [Related]
19. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data. Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683 [TBL] [Abstract][Full Text] [Related]